Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus - Wikidata - awgldk - TriplyDB

Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus

Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus

http://www.wikidata.org/entity/Q37658803

about

Accelerated atherosclerosis in patients with SLE--mechanisms and management Systematic review of the quality of prognosis studies in systemic lupus erythematosus Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome Emerging role of adipokines in systemic lupus erythematosus.Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus Cell adhesion molecules as potential biomarkers of nephritis, damage and accelerated atherosclerosis in patients with SLE High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids.The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus.Adiponectin action: a combination of endocrine and autocrine/paracrine effects.Cardiovascular risk in pediatric-onset rheumatological diseases.Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.Perivascular adipose tissue of the descending thoracic aorta is associated with systemic lupus erythematosus and vascular calcification in women.Cardiometabolic comorbidities and rheumatic diseases: focus on the role of fat mass and adipokines.Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Pathogenesis and treatment of atherosclerosis in lupus.Association between serum/plasma adiponectin levels and immune-mediated diseases: a meta-analysis.Soluble E-selectin may predict progression of subclinical atherosclerosis, as measured by coronary artery calcium score and aorta calcium score, in women with systemic lupus erythematosus.Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.

P2860

Q26820245-443978A4-6285-4755-B5D1-28C27275EFDE Q26823668-5A90188E-3D6E-4087-811A-C2D87565EF44 Q28071723-05D8266F-47E3-4751-A9D6-3FC0FC8B547A Q30249547-6B3E7419-A083-4D27-ABA9-412BA4EF2626 Q33570432-A9FF7F5A-8CC9-4FD6-B2A4-702575B0EE91 Q33799781-14AABE07-822C-4119-9304-4D28CEB54C5C Q34512778-6066D1D6-FC37-4FBE-8A3E-A4A084C183DB Q35138355-D30F2981-7EA6-42CB-81ED-F67E58AB35D3 Q35169351-B722B452-EDA6-47CE-A814-16B00395C66C Q35971216-900F1C68-DAD8-48EE-8CF7-88E51FFA709D Q36903089-9AF69107-9524-48E2-A770-FF1DC04406A2 Q36934234-EE505156-956A-4CDB-BD9B-66B3F4E16219 Q37033345-5F2DA51F-956E-4BF6-A0A9-3A4A0F377782 Q37317843-D3157BC3-9AFA-47AF-8345-FABFDB6BC547 Q37869467-B21410BE-39FE-4831-9AAC-77A42468E48A Q38162490-27DF8590-A72F-4623-8314-473EC1F6103C Q38230699-4A7E88FF-923B-47CC-AC04-C73D1A26D95B Q38681632-245165A2-0DB8-4701-872B-2EB17EC5ED71 Q46230857-85B51193-7A74-404E-9CDC-738F9D7C1DAF Q50052184-C345FC09-C5D8-4D4F-97B1-8FB95DD8B2A8 Q51076609-981525CD-E975-4371-8FA2-A9588AD34AC3

P2860

Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus

http://www.wikidata.org/entity/Q37658803

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Association of plasma soluble ...... h systemic lupus erythematosus

@en

Association of plasma soluble ...... systemic lupus erythematosus.

@nl

type

label

Association of plasma soluble ...... h systemic lupus erythematosus

@en

Association of plasma soluble ...... systemic lupus erythematosus.

@nl

prefLabel

Association of plasma soluble ...... h systemic lupus erythematosus

@en

Association of plasma soluble ...... systemic lupus erythematosus.

@nl

P1433

Q37658803-91546682-4AD6-49B7-BEA5-15ADD15073EF

P1476

Q37658803-A7725BD6-5F42-4146-A33C-D9567A2F8EC9

P2093

Q37658803-2F666563-3B18-4073-8A1B-1EB4702C5500

Q37658803-565F370C-AE31-4359-9AC9-FDA7C30C959F

Q37658803-72AABF4E-1882-44DB-956E-2032EBA69645

Q37658803-85705F7A-E566-474E-97A5-3411140F8A0D

Q37658803-8F56466A-721A-424F-AED7-D18DE63B13AE

Q37658803-DE85A53C-C421-4507-83C8-EE0175C934AC

P2860

Q37658803-04B162C6-1B69-4E19-95CF-974FFAD8E4CB

Q37658803-12817B26-F860-4522-A6CA-FC85B6A1BE55

Q37658803-19124479-4684-43EA-B923-977DB4079293

Q37658803-1BFC1E4C-02C8-497C-80DB-BB24AEEA0503

Q37658803-1DDA8BB6-1738-4FEE-9220-79E134C35ED9

Q37658803-2220655F-7EAB-4A90-8AC4-A5973173674D

Q37658803-27E91AE4-3A08-43FF-8234-C49CEC37CE4F

Q37658803-283498ED-1092-4E61-91C0-4B71D537B82D

Q37658803-297F6A4B-1510-4D16-A512-CE3BA86B762C

Q37658803-2DF17B71-80C9-4EC8-977F-09D47E219641

P304

Q37658803-C05AAD2B-C262-46F7-875E-A84D715F0B32

P31

Q37658803-4F7DEE8D-0E5D-41DD-9BCC-6FC40136B9E8

P356

Q37658803-617ADF88-8E0B-4BEA-AB40-C9AF6D279258

P433

Q37658803-F06E78FE-C1EE-4267-AFE7-706ED9552FD9

P478

Q37658803-BD23E676-9DC8-4623-B2CD-E28CBAF5F291

P50

Q37658803-2461E4CA-1600-480F-B211-577F5B1DA675

P577

Q37658803-A2783286-AF32-4188-96F4-4545287205BA

P698

Q37658803-F7BBCBCC-68AB-4469-8E06-612F0A2791D1

P932

Q37658803-5D3837BB-9C9A-412C-8624-293CE066A3B2

P356

J.ATHEROSCLEROSIS.2009.12.007

P1433

Atherosclerosis

P1476

Association of plasma soluble ...... h systemic lupus erythematosus

@en

P2093

Jill Buyon

http://www.w3.org/2001/XMLSchema#string

Mimi Kim

http://www.w3.org/2001/XMLSchema#string

Paul Tunick

http://www.w3.org/2001/XMLSchema#string

Peter Izmirly

http://www.w3.org/2001/XMLSchema#string

Robert M Clancy

http://www.w3.org/2001/XMLSchema#string

Tania L Rivera

http://www.w3.org/2001/XMLSchema#string

P2860

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention

The 1982 revised criteria for the classification of systemic lupus erythematosus

Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling.

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

Premature coronary-artery atherosclerosis in systemic lupus erythematosus.

Adiponectin actions in the cardiovascular system.

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Cardiovascular manifestations of systemic lupus erythematosus.

P304

569-574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ATHEROSCLEROSIS.2009.12.007

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

210

http://www.w3.org/2001/XMLSchema#string

P50

Harmony R Reynolds

P577

2009-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20044088

http://www.w3.org/2001/XMLSchema#string

P932

3963602

http://www.w3.org/2001/XMLSchema#string